⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL130843 | 0.69 | — | — | |
| SCHEMBL1966530 | 0.69 | — | — | |
| SCHEMBL1752553 | 0.67 | — | — | |
| SCHEMBL9889435 | 0.67 | — | — | |
| SCHEMBL15884464 | 0.67 | — | — | |
| SCHEMBL671347 | 0.67 | — | — | |
| SCHEMBL8081642 | 0.67 | — | — | |
| SCHEMBL4497202 | 0.67 | — | — | |
| SCHEMBL3707246 | 0.67 | — | — | |
| SCHEMBL360179 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1802591-A1 | QUINAZOLINE DERIVATIVES | AstraZeneca AB (SE) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006040520-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2006-04-20 | — | — | WO | disclosed |